Metolazone Associated Stevens Johnson Syndrome-Toxic Epidermal Necrolysis Overlap
- PMID: 27134890
- PMCID: PMC4843276
- DOI: 10.7860/JCDR/2016/17768.7404
Metolazone Associated Stevens Johnson Syndrome-Toxic Epidermal Necrolysis Overlap
Abstract
Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are severe mucocutaneous disease with high mortality rate. It is characterised by severe necrosis and detachment of the epidermis. Drugs are the most common triggering agent for SJS/TEN. These are commonly reported with the use of aromatic antiepileptics, antiretrovirals, allopurinol, NSAID'S and sulfonamide antibiotics. Non antibiotic sulfonamides rarely cause SJS/TEN. Metolazone is a well known diuretic and is extensively used by clinicians. Although this drug is in market for last several decades, no case of SJS/TEN has been reported till date. We report a rare case of metolazone induced SJS/TEN overlap in a 55-year-old lady.
Keywords: Naranjo Probability Scale; SCORTEN score; Thiazide diuretic.
Figures
Similar articles
-
A Compilation of Drug Etiologies of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.Cureus. 2023 Nov 13;15(11):e48728. doi: 10.7759/cureus.48728. eCollection 2023 Nov. Cureus. 2023. PMID: 38094551 Free PMC article. Review.
-
Toxic epidermal necrolysis and Stevens-Johnson syndrome.Orphanet J Rare Dis. 2010 Dec 16;5:39. doi: 10.1186/1750-1172-5-39. Orphanet J Rare Dis. 2010. PMID: 21162721 Free PMC article. Review.
-
Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.Am J Ophthalmol. 2010 Oct;150(4):505-510.e1. doi: 10.1016/j.ajo.2010.04.026. Epub 2010 Jul 8. Am J Ophthalmol. 2010. PMID: 20619392
-
Improving mortality outcomes of Stevens Johnson syndrome/toxic epidermal necrolysis: A regional burns centre experience.Burns. 2018 May;44(3):603-611. doi: 10.1016/j.burns.2017.09.015. Epub 2017 Oct 10. Burns. 2018. PMID: 29029855
-
Nine years of a single referral center management of Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell's syndrome).Cutan Ocul Toxicol. 2017 Jun;36(2):163-168. doi: 10.1080/15569527.2016.1218501. Epub 2016 Aug 22. Cutan Ocul Toxicol. 2017. PMID: 27487073
Cited by
-
Current Pharmacogenetic Perspective on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.Front Pharmacol. 2021 Apr 26;12:588063. doi: 10.3389/fphar.2021.588063. eCollection 2021. Front Pharmacol. 2021. PMID: 33981213 Free PMC article. Review.
-
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control Study.Drug Saf. 2019 Jan;42(1):55-66. doi: 10.1007/s40264-018-0711-x. Drug Saf. 2019. PMID: 30112729
-
A Life-Threatening Case of Torsemide-Induced Toxic Epidermal Necrolysis Associated With the Treatment of Anasarca.Cureus. 2022 Mar 6;14(3):e22895. doi: 10.7759/cureus.22895. eCollection 2022 Mar. Cureus. 2022. PMID: 35399474 Free PMC article.
-
A Compilation of Drug Etiologies of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.Cureus. 2023 Nov 13;15(11):e48728. doi: 10.7759/cureus.48728. eCollection 2023 Nov. Cureus. 2023. PMID: 38094551 Free PMC article. Review.
References
-
- Tomasini C, Derlino F, Quaglino P, Caproni M, Borroni G. From erythema multiforme to toxic epidermal necrolysis. Same spectrum or different diseases? G Ital Dermatol. Venereol. 2014;149(2):243–61. - PubMed
-
- Mockenhaupt M. The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis. Expert Rev Clin Immunol. 2011;7(6):803–13. - PubMed
-
- Rzany B, Mockenhaupt M, Baur S, Schröder W, Stocker U, Mueller J, et al. Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry. J Clin Epidemiol. 1996;49(7):769–73. - PubMed
-
- Schwartz RA, McDonough PH, Lee BW. Toxic epidermal necrolysis: Part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis. J Am Acad Dermatol. 2013;69(2):173. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources